Ending Animal Research: UK & US Pledges – Realistic or Revolutionary?

The use of animals in scientific research is facing increasing scrutiny, with both the United Kingdom and the United States governments signaling a commitment to reducing and ultimately phasing out animal testing. While the ethical considerations are paramount, the practicalities of such a shift are complex, raising questions about the future of medical research and product safety.

On November 11, 2025, the UK government unveiled a detailed roadmap outlining its plans to fulfill a manifesto pledge to work towards phasing out animal testing. This plan includes replacing animal testing for some major safety tests by the end of this year and a commitment to reduce the use of dogs and non-human primates in tests for human medicines by at least 35% by 2030.

Science Minister Lord Vallance acknowledged the ambition of the goal, stating that he could envision a future where animal use in science is “almost completely phased out,” but cautioned that this would not happen “anytime soon.” He emphasized the need to accelerate the development and adoption of alternative methods, including experiments on animal tissues grown from stem cells, artificial intelligence, and computer simulations. “Can we get very close to it? I think we can. Can we push faster than we have been? I think we can. Should we? We absolutely should,” he said.

The move comes after a period of decline in animal experimentation in the UK. Numbers peaked at 4.14 million in 2015, largely driven by an increase in genetic modification experiments, primarily on mice and fish. By 2020, the number had fallen to 2.88 million as alternative methods began to emerge. However, this decline has since plateaued, prompting the government to seek ways to re-ignite the downward trend.

The UK’s strategy is backed by £75 million in new funding aimed at accelerating the development of new testing methods for products designed to save lives. The government’s plan recognizes that phasing out animal testing is contingent on the availability of reliable and effective alternatives that can provide the same level of safety assurance for human exposure.

The roadmap also highlights the importance of collaboration between government, life sciences industries, and animal welfare organizations. This collaborative approach is seen as crucial for navigating the challenges of transitioning to alternative methods and ensuring that scientific progress is not hindered.

The Labour Party has also expressed support for phasing out animal testing, stating in its manifesto that it would “partner with scientists, industry, and civil society as we work towards the phasing out of animal testing.”

However, some scientists have expressed concerns about the pace of change. Reports suggest that a rapid reduction in animal tests could be “push[ing] too hard,” potentially impacting research timelines and the development of new treatments. The challenge lies in balancing the ethical imperative to reduce animal suffering with the need to maintain rigorous scientific standards and ensure public safety.

The development of alternative methods is a key focus of the new strategy. These include utilizing human cells in laboratory experiments, employing AI and computer modeling to predict the effects of substances, and growing animal tissues from stem cells to create more realistic models for testing. These approaches aim to replicate the complexity of biological systems more accurately than traditional animal models, while also reducing the ethical concerns associated with animal use.

The UK government’s plan builds on a broader global movement towards reducing animal testing. The United States government has also pledged to end research using animals, though the specific timelines and strategies for achieving this goal remain under development. The shared commitment from both governments signals a growing international consensus on the need to prioritize animal welfare in scientific research.

While the complete elimination of animal testing in the foreseeable future may not be realistic, as Lord Vallance suggests, the current initiatives represent a significant step towards reducing reliance on animals in science and accelerating the development of more humane and effective research methods. The success of these efforts will depend on continued investment in alternative technologies, close collaboration between stakeholders, and a commitment to maintaining the highest standards of scientific rigor.